Fundz

Invizius raised £950,000 in a funding round led by Mercia Ventures to prepare for the next stage of clinical trials for its H-Guard dialysis treatment.

PRIVATESep 23, 2024

Amount Raised

£950,000

Round Type

Series B

MotherwellBiotechnologyHealth CareMedical

Investors

Scottish EnterpriseUniversity Of Edinburgh’s Old College CapitalSyensqoCalculus CapitalMercia Ventures

Description

Edinburgh-based biotech Invizius has secured £950,000 in funding led by Mercia Ventures. The investment will support the progression of clinical trials for H-Guard, a treatment addressing inflammatory responses during dialysis.

Quick answer

Invizius raised £950,000 in a Series B round, dated September 23, 2024. Investors: Scottish Enterprise, University Of Edinburgh’s Old College Capital, Syensqo, Calculus Capital and Mercia Ventures. Invizius is based in Motherwell, Scotland, United Kingdom.

How much did Invizius raise?
Invizius raised £950,000 in a Series B round on September 23, 2024.
Who invested in Invizius?
Scottish Enterprise, University Of Edinburgh’s Old College Capital, Syensqo, Calculus Capital and Mercia Ventures are named as investors in this round.
What does Invizius do?
Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland.
Where is Invizius based and how big is it?
Invizius is based in Motherwell, Scotland, United Kingdom.
Who are the decision-makers at Invizius?
Fundz holds 1 contact at Invizius. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Invizius that raised within 45 days of this round, from Fundz verified event records.

  • Inquis Medical raised $40M (Series B) on November 4, 2024.
  • Persperity Health raised $1M (Pre-Seed) on November 1, 2024.
  • Innoventric raised $29M (Series B) on November 1, 2024.
  • Zenflow raised $19M on November 1, 2024.
  • Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.
  • Definition Health raised $7.4M (Pre-Seed) on October 31, 2024.

Who to call at Invizius, and when

A new round usually means Invizius is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Invizius raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Invizius, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Invizius. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Invizius

Location

Motherwell, Scotland, United Kingdom

About

Invizius is a spin-out based on world-class research carried out at the University of Edinburgh, Scotland. Invizius is developing Second Generation Complement Therapeutics to significantly improve the clinical outcomes of patients with Acute Kidney Injury receiving CRRT and patient on Renal replacement Therapy receiving Peritoneal Dialysis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Invizius raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Invizius's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Invizius raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.